Pipette Eczema
FDA Label NDC 73517-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amyris, Inc for the product Pipette Eczema (NDC 73517-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, active ingredients, purpose, uses, warnings, when using this product:, stop use and ask a doctor if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Drug Facts

Active Ingredients

Colloidal Oatmeal 1 %

Purpose

Skin protectant

Uses

Temporarily protects and helps relieve minor skin irritation and itching due to: 

• eczema • rashes

Warnings

  • For external use only

When Using This Product:

  • do not get into eyes

Stop Use And Ask A Doctor If

  • condition worsens 
  • symptoms last more than 7 days or clear up and occur again within a few days

Keep Out Of Reach Of Children.

  • If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply as needed

Other Information

Protect this product from excessive heat and direct sun.

Inactive Ingredients

Water, Squalane, Caprylic/Capric Triglyceride, Glycerin, Hydrogenated Sunflower Seed Oil Polyglyceryl-3 Esters, Hydroxystearic/Linolenic/Oleic Polyglycerides, Butyrospermum Parkii (Shea) Butter, Jojoba Esters, Ceramide NP, Tocopherol, Sodium Phytate, Hydrogenated Sunflower Seed Oil, Glyceryl Esters, Cetearyl Alcohol, Propanediol, Hydroxyacetophenone, Sodium Stearoyl Lactylate, Xanthan Gum, Ethylhexylglycerin, Potassium Sorbate, Citric Acid.

Questions Or Comments?

Call 855-747-2229

Package Labeling:73517-001-01

Add image transcription here...

Add image transcription here...

* Please review the disclaimer below.